Aspiring to Pharmaceuticals, Milagen Hopes To Sell Antibodies, Arrays in the Short Run | GenomeWeb

In recent months, as it has become apparent that many proteomics researchers have a strong interest in gaining access to collections of antibodies, public organizations have begun to take initial steps toward satisfying the pent-up demand. HUPO hopes to spearhead an effort to produce libraries of anti-bodies for public consumption, as has its affiliate in Germany, the German Society for Proteome Research.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.